Know the real price before you ask.

Weight & Metabolism

Tirzepatide is a dual GIP/GLP-1 receptor agonist — meaning it activates both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors simultaneously. This dual mechanism makes it one of the most potent metabolic research compounds currently under study. FDA-approved as Mounjaro and Zepbound, clinical trials have shown average weight loss of 20-22% of body weight, surpassing semaglutide in head-to-head comparisons.

Weight & Metabolism

Standard-dose GLP-1 receptor agonist for metabolic research. FDA-approved compound (Ozempic/Wegovy) studied for type 2 diabetes, obesity, and cardiovascular risk reduction.

Weight & Metabolism

Triple agonist (GLP-1, GIP, glucagon) for advanced metabolic research. Potent weight loss and glucose control compound under clinical investigation.

Recovery & Repair

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. It has gained significant attention in research for its remarkable regenerative properties. Studies suggest it accelerates healing of tendons, ligaments, muscles, and bones by promoting angiogenesis and upregulating growth hormone receptors. It also demonstrates potent gastroprotective effects, potentially aiding conditions like inflammatory bowel disease and leaky gut. Researchers are exploring its neuroprotective qualities as well. Often called the 'Wolverine peptide' for its broad healing potential.

Recovery & Repair

Advanced healing and anti-inflammatory stack. BPC-157 for tissue repair, KPV for gut health, and GHK-Cu for skin regeneration.

Recovery & Repair

This synergistic blend combines BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4) — two of the most powerful regenerative peptides in research. BPC-157 excels at local tissue repair, tendon and gut healing, and neuroprotection, while TB-500 offers systemic healing properties that can reach injured areas remote from the injection site. Together they upregulate growth hormone receptors, promote angiogenesis, reduce inflammation, and accelerate recovery from acute and chronic injuries. This combination is a cornerstone of research-based injury recovery protocols.

Recovery & Repair

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide present in virtually all human and animal cells. It plays a critical role in building new blood vessels, muscle tissue, and skin. Research highlights its ability to promote cellular migration and proliferation, making it a strong candidate for accelerating wound healing and reducing acute and chronic pain from injuries. It is particularly studied for its anti-inflammatory properties and its potential to improve flexibility and reduce muscle spasms. Unlike some peptides, TB-500 can work on areas remote from the injection site, providing systemic healing effects.

Skin & Appearance

High-dose copper peptide for skin regeneration, collagen synthesis, and wound healing research. GHK-Cu resets skin gene expression to a more youthful state and has potent anti-inflammatory properties.

Growth & Performance

A classic and highly studied GHRH/GHRP combination stack. CJC-1295 without DAC (also called Modified GRF 1-29) is a short-acting GHRH analogue that produces a strong, physiological GH pulse when combined with a GHRP. Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without significantly raising cortisol or prolactin. Together, they act synergistically — CJC-1295 amplifies the size of GH pulses while Ipamorelin increases pulse frequency and selectivity. This stack is one of the most researched and trusted protocols for GH optimization, muscle recovery, fat metabolism, and sleep quality improvement.

Growth & Performance

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analogue of Growth Hormone Releasing Hormone (GHRH). The DAC modification allows it to bind to albumin in the bloodstream, dramatically extending its half-life to approximately 6-8 days compared to just minutes for natural GHRH. This enables sustained elevation of GH and IGF-1 levels with less frequent dosing. Research suggests it can significantly increase lean muscle mass, support fat loss, improve sleep quality, and enhance recovery. It is often studied alongside a GHRP like Ipamorelin for a comprehensive GH optimization protocol.

Growth & Performance

Higher-dose short-acting GHRH analogue for enhanced pulsatile GH secretion research. Produces physiological GH pulses without the prolonged elevation associated with DAC modification.

Growth & Performance

Ipamorelin is a selective Growth Hormone Secretagogue (GHS) and ghrelin receptor agonist. It is highly regarded in research for stimulating significant GH release from the pituitary gland with a strong safety profile — notably, it does not significantly raise cortisol, prolactin, or aldosterone levels, which is a common concern with other GH secretagogues. This selectivity makes it one of the cleanest and most studied GHRPs available. Research suggests benefits including increased lean muscle mass, accelerated fat metabolism, improved sleep architecture (particularly slow-wave sleep), enhanced recovery, and potential anti-aging effects.

Growth & Performance

Higher-dose GHRH analog for enhanced growth hormone stimulation. Supports muscle growth, fat loss, and cellular regeneration.

Weight & Metabolism

AOD-9604 is a modified fragment of the human growth hormone molecule, specifically the C-terminal fragment (Tyr-hGH177-191). It was originally developed by Monash University to combat obesity by mimicking the way natural HGH regulates fat metabolism, but without the adverse effects on blood sugar or growth that full HGH can cause. Research indicates it stimulates lipolysis (the breakdown of fat) and inhibits lipogenesis (the transformation of food into body fat). Unlike HGH, it does not appear to affect IGF-1 levels or cause insulin resistance. It has also been studied for its potential regenerative effects on cartilage and bone.

Weight & Metabolism

Higher-dose NNMT inhibitor for comprehensive metabolic research. Blocks nicotinamide N-methyltransferase to increase NAD+ availability and activate fat-burning metabolic programs.

Weight & Metabolism

Proapoptotic peptide that targets blood vessels supplying white adipose tissue. Researched for targeted fat reduction and obesity treatment by inducing apoptosis in adipose vasculature.

Skin & Appearance

Higher-dose AHK-Cu copper peptide for advanced skin and hair regeneration research. Promotes collagen/elastin synthesis, reduces oxidative damage, and supports hair follicle proliferation.

Growth & Performance

AMPK activator that mimics the metabolic effects of exercise at the cellular level. Researched for endurance enhancement, fat oxidation, glucose uptake, and metabolic adaptation without physical activity.

Recovery & Repair

Erythropoietin-derived peptide that activates the innate repair receptor without stimulating red blood cell production. Researched for neuropathy, wound healing, and tissue protection with no hematopoietic effects.

Growth & Performance

Vitamin B12 (1mg/ml, 10ml per bottle) for energy metabolism, neurological function, and red blood cell formation. Essential cofactor researched for fatigue, neuropathy, and metabolic health support.

Research Supplies

Bacteriostatic Water (BAC Water) is sterile water containing 0.9% benzyl alcohol, which inhibits the growth of bacteria. It is the standard reconstitution solution for lyophilized (freeze-dried) peptides and research compounds. The benzyl alcohol preservative allows for multiple punctures of the vial without contamination risk and extends the stability of reconstituted peptides compared to plain sterile water. Essential for any peptide research protocol — always use BAC water to reconstitute peptide vials unless otherwise specified.

Weight & Metabolism

Cagrilintide is a long-acting amylin analogue currently being studied in combination with semaglutide (as 'CagriSema') for obesity treatment. Amylin is a hormone co-secreted with insulin that promotes satiety, slows gastric emptying, and reduces glucagon secretion. Cagrilintide's extended half-life allows for once-weekly dosing. In research trials, the combination of cagrilintide and semaglutide has shown additive and potentially synergistic weight loss effects, with phase 3 trials showing greater weight reduction than either agent alone. It represents a promising next frontier in multi-hormonal metabolic therapy beyond GLP-1 monotherapy.

Weight & Metabolism

High-dose CagriSema for advanced dual-hormone metabolic research. Maximum combined amylin/GLP-1 agonism for studying synergistic satiety, gastric emptying, and metabolic regulation.

Brain & Sleep

Higher-dose delta sleep-inducing peptide for comprehensive sleep and stress research. Studied for neuroprotection, stress hormone normalization, and deep sleep enhancement.